Veterinary Infectious Diseases Therapeutics Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : December 2020 Pages : 157 Category: Pharma & Healthcare Report Code : HC1214336
Veterinary Infectious Diseases Therapeutics Market by Type(Antiviral,Amebicides,Antibiotics,Antifungal,Anthelmintics)Application (Chicken, Cow, Horse, Dog, Cat, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Veterinary Infectious Diseases TherapeuticsMarket has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.A contagious veterinary disease is a disease that can be transmitted by pathogenic microorganisms from one animal to another or from another human being.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Novartis Animal Health
- Elanco Animal Health
- Merck
- Sanofi
- Pfizer Animal Health
- BoehringerIngelheimVetmedica
- CevaSanteAnimale
- Dechra Animal Health
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Veterinary Infectious Diseases Therapeutics Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Antiviral
o Amebicides
o Antibiotics
o Antifungal
o Anthelmintics
· Veterinary Infectious Diseases Therapeutics Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Chicken
o Cow
o Horse
o Dog
o Cat
· Veterinary Infectious Diseases Therapeutics Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Novartis Animal Health
o Elanco Animal Health
o Merck
o Sanofi
o Pfizer Animal Health
o BoehringerIngelheimVetmedica
o CevaSanteAnimale
o Dechra Animal Health
· Veterinary Infectious Diseases Therapeutics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Veterinary Infectious Diseases Therapeutics Market, By Country
o U.S. Veterinary Infectious Diseases Therapeutics Market
o Canada Veterinary Infectious Diseases Therapeutics Market
o Mexico Veterinary Infectious Diseases Therapeutics Market
o Europe
§ Europe Veterinary Infectious Diseases Therapeutics Market, By Country
· Germany Veterinary Infectious Diseases Therapeutics Market
o UK Veterinary Infectious Diseases Therapeutics Market
o France Veterinary Infectious Diseases Therapeutics Market
o RussiaVeterinary Infectious Diseases Therapeutics Market
o Italy Veterinary Infectious Diseases Therapeutics Market
o Rest of Europe Veterinary Infectious Diseases Therapeutics Market
o Asia-Pacific
§ Asia-Pacific Veterinary Infectious Diseases Therapeutics Market, By Country
o ChinaVeterinary Infectious Diseases Therapeutics Market
o Japan Veterinary Infectious Diseases Therapeutics Market
o South KoreaVeterinary Infectious Diseases Therapeutics Market
o India Veterinary Infectious Diseases Therapeutics Market
o Southeast AsiaVeterinary Infectious Diseases Therapeutics Market
o Rest of Asia-Pacific Veterinary Infectious Diseases Therapeutics Market
o South America
§ South AmericaVeterinary Infectious Diseases Therapeutics Market
o Brazil Veterinary Infectious Diseases Therapeutics Market
o ArgentinaVeterinary Infectious Diseases Therapeutics Market
o ColumbiaVeterinary Infectious Diseases Therapeutics Market
o Rest of South America Veterinary Infectious Diseases Therapeutics Market
o Middle East and Africa
§ Middle East and AfricaVeterinary Infectious Diseases Therapeutics Market
o Saudi ArabiaVeterinary Infectious Diseases Therapeutics Market
o UAEVeterinary Infectious Diseases Therapeutics Market
o EgyptVeterinary Infectious Diseases Therapeutics Market
o NigeriaVeterinary Infectious Diseases Therapeutics Market
o South Africa Veterinary Infectious Diseases Therapeutics Market
o Rest of MEA Veterinary Infectious Diseases Therapeutics Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Veterinary Infectious Diseases Therapeutics Market, By Type
5.1. Introduction
5.2. Global Veterinary Infectious Diseases Therapeutics Revenue and Market Share by Type (2017-2021)
5.2.1. Global Veterinary Infectious Diseases Therapeutics Revenue and Revenue Share by Type (2017-2021)
5.3. Antiviral
5.3.1. Global Antiviral Revenue and Growth Rate (2017-2021)
5.4. Amebicides
5.4.1. Global Amebicides Revenue and Growth Rate (2017-2021)
5.5. Antibiotics
5.5.1. Global Antibiotics Revenue and Growth Rate (2017-2021)
5.6. Antifungal
5.6.1. Global Antifungal Revenue and Growth Rate (2017-2021)
5.7. Anthelmintics
5.7.1. Global Anthelmintics Revenue and Growth Rate (2017-2021)
6. Veterinary Infectious Diseases Therapeutics Market, By Application
6.1. Introduction
6.2. Global Veterinary Infectious Diseases Therapeutics Revenue and Market Share by Application (2017-2021)
6.2.1. Global Veterinary Infectious Diseases Therapeutics Revenue and Revenue Share by Application (2017-2021)
6.3. Chicken
6.3.1. Global Chicken Revenue and Growth Rate (2017-2021)
6.4. Cat
6.4.1. Global Cat Revenue and Growth Rate (2017-2021)
6.5. Dog
6.5.1. Global Dog Revenue and Growth Rate (2017-2021)
6.6. Horse
6.6.1. Global Horse Revenue and Growth Rate (2017-2021)
6.7. Cow
6.7.1. Global Cow Revenue and Growth Rate (2017-2021)
6.8. Others
6.8.1. Global Others Revenue and Growth Rate (2017-2021)
7. Veterinary Infectious Diseases Therapeutics Market, By Region
7.1. Introduction
7.2. Global Veterinary Infectious Diseases Therapeutics Revenue and Market Share by Regions
7.2.1. Global Veterinary Infectious Diseases Therapeutics Revenue by Regions (2017-2021)
7.3. North America Veterinary Infectious Diseases Therapeutics by Countries
7.3.1. North America Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2021)
7.3.2. North America Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Veterinary Infectious Diseases Therapeutics by Countries
7.4.1. Europe Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2021)
7.4.2. Europe Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Veterinary Infectious Diseases Therapeutics by Countries
7.5.1. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Veterinary Infectious Diseases Therapeutics by Countries
7.6.1. South America Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2021)
7.6.2. South America Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Veterinary Infectious Diseases Therapeutics by Countries
7.7.1. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Novartis Animal Health
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Elanco Animal Health
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Merck
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Sanofi
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Pfizer Animal Health
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Boehringer Ingelheim Vetmedica
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Ceva Sante Animale
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Dechra Animal Health
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.1. Global Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Veterinary Infectious Diseases Therapeutics Market Forecast by Regions (2022-2027)
9.2.1. North America Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.1.1. United States Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.1.2. Canada Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.1.3. Mexico Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.2. Europe Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.2.1. Germany Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.2.2. France Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.2.3. UK Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.2.4. Russia Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.2.5. Italy Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.3. Asia-Pacific Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.3.1. China Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.3.2. Japan Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.3.3. Korea Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.3.4. India Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.4. South America Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.4.1. Brazil Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.4.2. Argentina Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.4.3. Columbia Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.4.4. Rest of South America Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5. Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5.3. Egypt Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5.4. Nigeria Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5.5. South Africa Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5.6. Turkey Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Forecast (2022-2027)
9.3. Veterinary Infectious Diseases Therapeutics Market Forecast by Type (2022-2027)
9.3.1. Veterinary Infectious Diseases Therapeutics Forecast by Type (2022-2027)
9.3.2. Veterinary Infectious Diseases Therapeutics Market Share Forecast by Type (2022-2027)
9.4. Veterinary Infectious Diseases Therapeutics Market Forecast by Application (2022-2027)
9.4.1. Veterinary Infectious Diseases Therapeutics Forecast by Application (2022-2027)
9.4.2. Veterinary Infectious Diseases Therapeutics Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Veterinary Infectious Diseases Therapeutics Revenue and Revenue Share by Type (2017-2019)
Figure Global Antiviral Revenue and Growth Rate (2017-2019)
Figure Global Amebicides Revenue and Growth Rate (2017-2019)
Figure Global Antibiotics Revenue and Growth Rate (2017-2019)
Figure Global Antifungal Revenue and Growth Rate (2017-2019)
Figure Global Anthelmintics Revenue and Growth Rate (2017-2019)
Table Global Veterinary Infectious Diseases Therapeutics Revenue and Revenue Share by Application (2017-2019)
Figure Global Chicken Revenue and Growth Rate (2017-2019)
Figure Global Cat Revenue and Growth Rate (2017-2019)
Figure Global Dog Revenue and Growth Rate (2017-2019)
Figure Global Horse Revenue and Growth Rate (2017-2019)
Figure Global Cow Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Veterinary Infectious Diseases Therapeutics Revenue by Regions (2017-2019)
Figure North America Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure North America Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2019)
Figure North America Veterinary Infectious Diseases Therapeutics by Countries (2017-2019)
Figure North America Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2019)
Figure United States Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure United States Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Canada Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Mexico Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Europe Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2019)
Figure Europe Veterinary Infectious Diseases Therapeutics by Countries (2017-2019)
Figure Europe Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2019)
Figure Germany Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Germany Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure France Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure UK Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Russia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Italy Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Rest of Europe Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Veterinary Infectious Diseases Therapeutics by Countries (2017-2019)
Figure Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2019)
Figure China Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure China Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Japan Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Korea Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure India Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure South America Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2019)
Figure South America Veterinary Infectious Diseases Therapeutics by Countries (2017-2019)
Figure South America Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Brazil Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Argentina Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Columbia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Rest of South America Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics by Countries (2017-2019)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure United Arab Emirates Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Egypt Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Nigeria Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure South Africa Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Turkey Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Veterinary Infectious Diseases Therapeutics Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2017-2019)
Table Novartis Animal Health Veterinary Infectious Diseases Therapeutics Financial Overview
Table Elanco Animal Health Veterinary Infectious Diseases Therapeutics Financial Overview
Table Merck Veterinary Infectious Diseases Therapeutics Financial Overview
Table Sanofi Veterinary Infectious Diseases Therapeutics Financial Overview
Table Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Financial Overview
Table Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Financial Overview
Table Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Financial Overview
Table Dechra Animal Health Veterinary Infectious Diseases Therapeutics Financial Overview
Figure Global Veterinary Infectious Diseases Therapeutics Revenue (Millions USD) and Growth Rate (2019-2027)
Table Veterinary Infectious Diseases Therapeutics Market Forecast by Regions (2019-2027)
Figure North America Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure United States Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Canada Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Mexico Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Europe Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Germany Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure France Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure UK Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Russia Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Italy Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Rest of Europe Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Asia-Pacific Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure China Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Japan Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Korea Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure India Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Southeast Asia Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure South America Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Brazil Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Argentina Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Columbia Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Rest of South America Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Saudi Arabia Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure United Arab Emirates Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Egypt Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Nigeria Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure South Africa Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Turkey Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Forecast (2019-2027)
Figure Global Veterinary Infectious Diseases Therapeutics Forecast by Type (2019-2027)
Figure Global Veterinary Infectious Diseases Therapeutics Market Share Forecast by Type (2019-2027)
Figure Global Veterinary Infectious Diseases Therapeutics Forecast by Type (2019-2027)
Figure Global Veterinary Infectious Diseases Therapeutics Forecast by Application (2019-2027)
Figure Global Veterinary Infectious Diseases Therapeutics Market Share Forecast by Application (2019-2027)
Figure Global Veterinary Infectious Diseases Therapeutics Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|